Search Results - "Schwager, M. M."

Persistent Robotic Tasks: Monitoring and Sweeping in Changing Environments by Smith, S. L., Schwager, M., Rus, D.

“…In this paper, we present controllers that enable mobile robots to persistently monitor or sweep a changing environment. The environment is modeled as a field…”
Get full text

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center by Wang, Yucai, Tschautscher, Marcella A, Rabe, Kari G, Call, Timothy G, Leis, Jose F, Kenderian, Saad S, Kay, Neil E, Muchtar, Eli, Van Dyke, Daniel L, Koehler, Amber B, Schwager, Susan M, Slager, Susan L, Parikh, Sameer A, Ding, Wei

“…The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We…”
Get full text

Animal species diversity driven by habitat heterogeneity/diversity: the importance of keystone structures by Tews, J., Brose, U., Grimm, V., Tielbörger, K., Wichmann, M. C., Schwager, M., Jeltsch, F.

“…Aim In a selected literature survey we reviewed studies on the habitat heterogeneity-animal species diversity relationship and evaluated whether there are…”
Get full text

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience by Strati, Paolo, Nasr, Samih H, Leung, Nelson, Hanson, Curtis A, Chaffee, Kari G, Schwager, Susan M, Achenbach, Sara J, Call, Timothy G, Parikh, Sameer A, Ding, Wei, Kay, Neil E, Shanafelt, Tait D

“…While the renal complications of plasma cell dyscrasia have been well-described, most information in patients with chronic lymphocytic leukemia and monoclonal…”
Get full text

The influence of porous transport layer modifications on the water management in polymer electrolyte membrane fuel cells by Alink, R., Haußmann, J., Markötter, H., Schwager, M., Manke, I., Gerteisen, D.

“…In this study, the influence of modifications of the porous transport layer (PTL) on the water management in polymer electrolyte membrane fuel cells is…”
Get full text

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors by Wolanskyj, Alexandra P, Schwager, Susan M, McClure, Rebecca F, Larson, Dirk R, Tefferi, Ayalew

“…To describe the long-term natural history of essential thrombocythemia (ET) in terms of life expectancy, risk of disease transformation Into a more aggressive…”
Get more information

The efficacy of ibrutinib in the treatment of Richter syndrome by Tsang, Mazie, Shanafelt, Tait D., Call, Timothy G., Ding, Wei, Chanan-Khan, Asher, Leis, Jose F., Nowakowski, Grzegorz S., Bowen, Deborah, Conte, Michael, Schwager, Susan M., Slager, Susan L., Kay, Neil E., Hanson, Curtis A., Parikh, Sameer A.

Get full text

Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch by Ding, Wei, Knox, Traci R., Tschumper, Renee C., Wu, Wenting, Schwager, Susan M., Boysen, Justin C., Jelinek, Diane F., Kay, Neil E.

“…Malignant cells are capable of influencing the microenvironment in a manner that facilitates tumor cell survival. Bidirectional crosstalk between chronic…”
Get full text

Invasive populations of Spiraea tomentosa (Rosaceae) are genetically diverse but decline during succession in forest habitats by Lorenz, J., Heinrich, R., Schneider, A., Schwager, M., Herklotz, V., Wesche, K., Ritz, C. M., Byers, D.

“…Population genetic and ecological data may help to control invasive plants, which are considered a major threat to natural habitats. In contrast to expected…”
Get full text

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes by Parikh, Sameer A, Rabe, Kari G, Kay, Neil E, Call, Timothy G, Ding, Wei, Schwager, Susan M, Bowen, Deborah A, Conte, Michael, Jelinek, Diane F, Slager, Susan L, Shanafelt, Tait D

“…The clinical characteristics and outcomes of younger (≤ 55 years) patients with chronic lymphocytic leukemia in the era of modern prognostic biomarkers and…”
Get full text

New species from Phytophthora Clade 6a: evidence for recent radiation by Burgess, T I, Simamora, A V, White, D, Wiliams, B, Schwager, M, Stukely, M J C, Hardy, G E St J

“…During routine vegetation health surveys in the southwest of Western Australia (SWWA), several Phytophthora isolates with affinity to Clade 6a have been…”
Get full text

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes by Fang, Hong, Reichard, Kaaren K., Rabe, Kari G., Hanson, Curtis A., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Muchtar, Eli, Schwager, Susan M., Leis, Jose F., Chanan‐Khan, Asher A., Slager, Susan L., Braggio, Esteban, Smoley, Stephanie A., Kay, Neil E., Shanafelt, Tait D., Van Dyke, Daniel L., Parikh, Sameer A.

“…The prevalence, clinicopathologic correlates, and outcomes of previously untreated chronic lymphocytic leukemia (CLL) patients with IGH‐BCL2 and IGH‐BCL3…”
Get full text

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis by Solomon, B M, Chaffee, K G, Moreira, J, Schwager, S M, Cerhan, J R, Call, T G, Kay, N E, Slager, S L, Shanafelt, T D

“…It is unknown whether individuals with monoclonal B-cell lymphocytosis (MBL) are at risk for adverse outcomes associated with chronic lymphocytic leukemia…”
Get full text

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice by Parikh, Sameer A., Achenbach, Sara J., Call, Timothy G., Rabe, Kari G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Chanan‐Khan, Asher A., Koehler, Amber B., Schwager, Susan M., Muchtar, Eli, Fonder, Amie L., McCullough, Kristen B., Nedved, Adrienne N., Smith, Matthew D., Slager, Susan L., Kay, Neil E., Finnes, Heidi D., Shanafelt, Tait D.

“…To study the impact of dose modification and temporary interruption of ibrutinib in routine clinical practice, we conducted a retrospective study of…”
Get full text

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor by Wang, Yucai, Rabe, Kari G, Bold, Michael S, Shi, Min, Hanson, Curtis A, Schwager, Susan M, Call, Timothy G, Kenderian, Saad S, Muchtar, Eli, Hayman, Suzanne R, Koehler, Amber B, Fonder, Amie L, Chanan-Khan, Asher A, Van Dyke, Daniel L, Slager, Susan L, Kay, Neil E, Ding, Wei, Leis, Jose F, Parikh, Sameer A

Get full text

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis by Parikh, Sameer A, Chaffee, Kari G, Larson, Melissa C, Hampel, Paul J, Call, Timothy G, Ding, Wei, Kenderian, Saad S, Leis, Jose F, Chanan-Khan, Asher A, Conte, Michael J, Bowen, Deborah, Schwager, Susan M, Slager, Susan L, Hanson, Curtis A, Kay, Neil E, Shanafelt, Tait D

Get full text

Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts by Schwager, Juan M, Di Maggio, Nunzia, Grosso, Andrea, Rasadurai, Abeelan, Minder, Nadja, Hubbell, Jeffrey A, Kappos, Elisabeth A, Schaefer, Dirk J, Briquez, Priscilla S, Banfi, Andrea, Burger, Maximilian G

“…The stromal vascular fraction (SVF) of human adipose tissue is an attractive cell source for engineering grafts with intrinsic vascularization potential, as it…”
Get full text

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? by King, Rebecca L., Gupta, Alia, Kurtin, Paul J., Ding, Wei, Call, Timothy G., Rabe, Kari G., Kenderian, Saad S., Leis, Jose F., Wang, Yucai, Schwager, Susan M., Slager, Susan L., Kay, Neil. E., Koehler, Amber, Ansell, Stephen M., Inwards, David J., Habermann, Thomas M., Shi, Min, Hanson, Curtis A., Howard, Matthew T., Parikh, Sameer A.

“…The distinction between chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with isolated Hodgkin/Reed–Sternberg cells (CLL-HRS; background…”
Get full text

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib by Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher A., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber B., Parrondo, Ricardo, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

“…Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to…”
Get full text

Results of epizootic monitoring of natural foci of particularly dangerous infections common to humans and animals in Rostov Oblast by Lukshina, E. Y., Batashev, V. V., Kovalev, E. V., Karpushchenko, G. V., Balakhnova, V. V., Panasyuk, N. V., Alieva, A. A., Sidelnikov, V. V., Schwager, M. M., Polovinka, N. V., Polonsky, A. V., Logvin, F. V., Tutunkova, N. G., Noskov, A. K.

“…Objective : To analyze the results of epizootic monitoring of natural foci of particularly dangerous infections common to humans and animals in Rostov Oblast…”
Get full text